Chapter 17. Melatonin and Malignant Disease

  1. David Evered Organizer and
  2. Sarah Clark
  1. Lawrence Tamarkin,
  2. Osborne F. X. Almeida and
  3. David N. Danforth Jr

Published Online: 30 MAY 2008

DOI: 10.1002/9780470720981.ch17

Ciba Foundation Symposium 117 - Photoperiodism, Melatonin and the Pineal

Ciba Foundation Symposium 117 - Photoperiodism, Melatonin and the Pineal

How to Cite

Tamarkin, L., Almeida, O. F. X. and Danforth, D. N. (2008) Melatonin and Malignant Disease, in Ciba Foundation Symposium 117 - Photoperiodism, Melatonin and the Pineal (eds D. Evered and S. Clark), John Wiley & Sons, Ltd., Chichester, UK. doi: 10.1002/9780470720981.ch17

Author Information

  1. Clinical Psychobiology Branch, National Institute of Mental Health, and Developmental Endocrinology Branch, National Insitute of Child Health and Human Development, and Surgery Branch, National Cancer Institute, National Institutes of Health, Washington, District of Columbia 20205 USA

Publication History

  1. Published Online: 30 MAY 2008
  2. Published Print: 1 JAN 1985

ISBN Information

Print ISBN: 9780272798218

Online ISBN: 9780470720981

SEARCH

Keywords:

  • melatonin;
  • malignant disease;
  • hormone-dependent tumours;
  • pinealectomy;
  • prolactin secretion

Summary

This chapter contains section titled:

  • Tumour Development in DMBA-treated Rats

  • Interactions of Melatonin with other Hormone Systems

  • Melatonin in Patients with Breast Cancer

  • References

  • Discussion

  • References

  • General discussion I

  • Melatonin Assay Technology (Summarized by Dr J. Arendt)

  • How Important is the Duration of the Melatonin Signal?

  • References